Showing results (941-950 of 1,996) with videos related to
Sort By:
Pageof 200
The Lancet. Neurology|October 20, 2012
Cognitive reserve in ageing and Alzheimer's diseaseYaakov SternThe Lancet. Neurology|March 20, 2010
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 casesDavid B Clifford, Andrea De Luca, Andrea DeLuca, et al.The Lancet. Neurology|October 12, 2012
Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trialMichael D Hill, Renee H Martin, David Mikulis, et al.The Lancet. Neurology|March 21, 2015
Role of the innate and adaptive immune responses in the course of multiple sclerosisBernhard Hemmer, Martin Kerschensteiner, Thomas KornThe Lancet. Neurology|March 21, 2015
Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatmentAndrew G Engel, Xin-Ming Shen, Duygu Selcen, et al.The Lancet. Neurology|August 13, 2022
Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort studyFrederick K Korley, Sonia Jain, Xiaoying Sun, et al.The Lancet. Neurology|August 13, 2022
Genetics of multiple sclerosis: lessons from polygenicityAn Goris, Marijne Vandebergh, Jacob L McCauley, et al.The Lancet. Neurology|June 21, 2020
Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trialDieter Volc, Werner Poewe, Alexandra Kutzelnigg, et al.The Lancet. Neurology|June 21, 2020
Brain injury after cardiac arrest: from prognostication of comatose patients to rehabilitationTobias Cronberg, David M Greer, Gisela Lilja, et al.Pageof 200